| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $739.4M | +6.5% | +17.7% |
| Cost of Revenue | $162.2M | +7.4% | +32.2% |
| R&D Expense | $127.9M | -4.7% | +8.7% |
| SG&A Expense | $131.3M | +0.3% | -5.4% |
| Operating Income | $161.2M | +38.1% | +48.6% |
| Pre-tax Income | $179.5M | +34.8% | +41.2% |
| Income Tax | $64.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $653.1M | -27.1% | -46.5% |
| Short-term Investments | $792.3M | +0.2% | +55.3% |
| Accounts Receivable | $3.48B | +6.9% | +16.4% |
| Current Assets | $5.12B | +1.3% | +5.8% |
| Total Assets | $5.94B | -0.3% | +7.9% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $681.1M | — | — |
| Capital Expenditures | $170.7M | — | — |
| Investing Cash Flow | -$412.9M | — | — |
| Financing Cash Flow | -$984.5M | — | — |
| Free Cash Flow | $510.4M | — | — |
| +48.5% |
| +93.7% |
| Net Income | $115.5M | +28.2% | +22.7% |
| EPS (Basic) | $0.24 | +33.3% | +26.3% |
| EPS (Diluted) | $0.23 | +27.8% | +21.1% |
| $2.99B |
| +1.6% |
| +14.5% |
| Total Liabilities | $3.34B | +2.4% | +16.0% |
| Stockholders' Equity | $2.60B | -3.5% | -1.0% |